Discover 517 paid clinical trials in Cedar Rapids, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 517
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
for
Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN
Location: Iowa City IA, Maple Grove MN, Ann Arbor MI, Columbus OH,
Sponsor: University of Iowa
Sex: All
Age: 0+
Code: NCT01193088
Recruiting
Continued Pressure for Alveolar Protection (CPAP Trial)
for
Bronchopulmonary Dysplasia (BPD)
Location: Iowa City IA, Chicago IL, Cincinnati OH, Cleveland OH,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT07417111
Recruiting
Pregnancy 24/7 Offspring Study
for
Healthy
Location: Iowa City IA, Morgantown WV
Sponsor: Kara Whitaker
Sex: All
Age: 0 - 47
Code: NCT07172880
Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
for
Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2,
Location: Iowa City IA, Grand Rapids MI, Flower Mound TX,
Sponsor: Scholar Rock, Inc.
Sex: All
Age: 0 - 2
Code: NCT07047144
Phase 2, Recruiting
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
for
Acute Ischemic Stroke From Large Vessel Occlusion
Location: Iowa City IA, Park Ridge IL, Milwaukee WI, Nashville TN,
Sponsor: Anaconda Biomed S.L.
Sex: All
Age: 22 - 70+
Code: NCT06370182
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
for
Urothelial Carcinoma Bladder,
Location: Iowa City IA, Westwood KS, Grand Rapids MI,
Sponsor: Aktis Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07020117
Phase 1, Recruiting
SPI-1005 in Adults Receiving Cochlear Implant
for
Hearing Loss, Cochlear Trauma
Location: Iowa City IA, Columbus OH, Dallas TX, Philadelphia PA,
Sponsor: Sound Pharmaceuticals, Incorporated
Sex: All
Age: 18+
Code: NCT06340633
Phase 2, Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma